Cypress Capital Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.33M | Buy |
138,473
+8,227
| +6% | +$215K | 0.31% | 76 |
|
|
2026
Q1 | $3.66M | Buy |
130,246
+6,603
| +5% | +$176K | 0.41% | 61 |
|
|
2025
Q4 | $3.08M | Buy |
123,643
+9,423
| +8% | +$238K | 0.34% | 68 |
|
|
2025
Q3 | $2.91M | Buy |
114,220
+102,210
| +851% | +$2.52M | 0.35% | 72 |
|
|
2025
Q2 | $291K | Sell |
12,010
-101,055
| -89% | -$2.36M | 0.04% | 195 |
|
|
2025
Q1 | $2.87M | Buy |
113,065
+8,968
| +9% | +$235K | 0.38% | 64 |
|
|
2024
Q4 | $2.76M | Sell |
104,097
-17,217
| -14% | -$467K | 0.34% | 66 |
|
|
2024
Q3 | $3.51M | Buy |
121,314
+3,196
| +3% | +$93.2K | 0.39% | 64 |
|
|
2024
Q2 | $3.3M | Sell |
118,118
-15,538
| -12% | -$428K | 0.4% | 61 |
|
|
2024
Q1 | $3.71M | Buy |
133,656
+12,518
| +10% | +$347K | 0.44% | 61 |
|
|
2023
Q4 | $3.49M | Buy |
121,138
+8,100
| +7% | +$245K | 0.45% | 58 |
|
|
2023
Q3 | $3.75M | Buy |
113,038
+2,312
| +2% | +$81.8K | 0.54% | 50 |
|
|
2023
Q2 | $4.06M | Sell |
110,726
-34,488
| -24% | -$1.34M | 0.59% | 46 |
|
|
2023
Q1 | $5.92M | Buy |
145,214
+1,363
| +0.9% | +$58.9K | 0.91% | 30 |
|
|
2022
Q4 | $7.37M | Buy |
143,851
+5,116
| +4% | +$245K | 1.11% | 20 |
|
|
2022
Q3 | $6.07M | Buy |
138,735
+18,256
| +15% | +$887K | 1.01% | 27 |
|
|
2022
Q2 | $6.32M | Buy |
120,479
+3,098
| +3% | +$158K | 0.96% | 27 |
|
|
2022
Q1 | $6.08M | Buy |
117,381
+18,379
| +19% | +$954K | 0.75% | 40 |
|
|
2021
Q4 | $5.85M | Buy |
99,002
+14,314
| +17% | +$709K | 0.73% | 38 |
|
|
2021
Q3 | $3.64M | Sell |
84,688
-249
| -0.3% | -$11K | 0.5% | 56 |
|
|
2021
Q2 | $3.33M | Buy |
84,937
+14,817
| +21% | +$576K | 0.45% | 64 |
|
|
2021
Q1 | $2.54M | Sell |
70,120
-3,826
| -5% | -$136K | 0.36% | 76 |
|
|
2020
Q4 | $2.72M | Sell |
73,946
-1,738
| -2% | -$63.8K | 0.41% | 64 |
|
|
2020
Q3 | $2.64M | Sell |
75,684
-8,206
| -10% | -$288K | 0.44% | 62 |
|
|
2020
Q2 | $2.6M | Buy |
83,890
+18,491
| +28% | +$628K | 0.48% | 62 |
|
|
2020
Q1 | $2.02M | Sell |
65,399
-15,187
| -19% | -$517K | 0.47% | 63 |
|
|
2019
Q4 | $3M | Sell |
80,586
-7,990
| -9% | -$285K | 0.53% | 58 |
|
|
2019
Q3 | $3.02M | Sell |
88,576
-8,340
| -9% | -$303K | 0.58% | 56 |
|
|
2019
Q2 | $3.98M | Sell |
96,916
-457
| -0.5% | -$18.1K | 0.79% | 41 |
|
|
2019
Q1 | $3.92M | Sell |
97,373
-1,699
| -2% | -$68K | 0.8% | 41 |
|
|
2018
Q4 | $4.1M | Sell |
99,072
-687
| -0.7% | -$28.5K | 0.94% | 33 |
|
|
2018
Q3 | $4.17M | Sell |
99,759
-441
| -0.4% | -$17K | 0.79% | 38 |
|
|
2018
Q2 | $3.45M | Sell |
100,200
-9,808
| -9% | -$335K | 0.71% | 46 |
|
|
2018
Q1 | $3.7M | Buy |
110,008
+3,088
| +3% | +$106K | 0.78% | 39 |
|
|
2017
Q4 | $3.67M | Buy |
106,920
+2,807
| +3% | +$95.7K | 0.76% | 44 |
|
|
2017
Q3 | $3.53M | Sell |
104,113
-16,384
| -14% | -$527K | 0.75% | 45 |
|
|
2017
Q2 | $3.84M | Sell |
120,497
-61,950
| -34% | -$1.95M | 0.85% | 39 |
|
|
2017
Q1 | $5.92M | Sell |
182,447
-15,072
| -8% | -$475K | 1.38% | 21 |
|
|
2016
Q4 | $6.09M | Sell |
197,519
-18,288
| -8% | -$558K | 1.45% | 22 |
|
|
2016
Q3 | $6.93M | Buy |
215,807
+2,208
| +1% | +$73.8K | 1.65% | 18 |
|
|
2016
Q2 | $7.14M | Buy |
213,599
+8,711
| +4% | +$278K | 1.67% | 17 |
|
|
2016
Q1 | $5.76M | Sell |
204,888
-1,318
| -0.6% | -$37.6K | 1.41% | 27 |
|
|
2015
Q4 | $6.32M | Buy |
206,206
+9,223
| +5% | +$290K | 1.52% | 21 |
|
|
2015
Q3 | $5.87M | Buy |
196,983
+3,734
| +2% | +$120K | 1.45% | 22 |
|
|
2015
Q2 | $6.15M | Buy |
193,249
+13,756
| +8% | +$448K | 1.42% | 24 |
|
|
2015
Q1 | $5.92M | Buy |
179,493
+116,377
| +184% | +$3.7M | 1.35% | 26 |
|
|
2014
Q4 | $1.86M | Buy |
63,116
+2,115
| +3% | +$60.6K | 0.43% | 68 |
|
|
2014
Q3 | $1.71M | Sell |
61,001
-235
| -0.4% | -$6.59K | 0.41% | 73 |
|
|
2014
Q2 | $1.72M | Buy |
61,236
+2,452
| +4% | +$69.9K | 0.4% | 75 |
|
|
2014
Q1 | $1.79M | Buy |
58,784
+8,947
| +18% | +$267K | 0.44% | 73 |
|
|
2013
Q4 | $1.45M | Sell |
49,837
-1,599
| -3% | -$46.5K | 0.36% | 75 |
|
|
2013
Q3 | $1.4M | Sell |
51,436
-5,726
| -10% | -$156K | 0.35% | 75 |
|
|
2013
Q2 | $1.52M | Buy |
+57,162
| New | +$1.58M | 0.32% | 81 |
|
Other funds holding PFE
Cypress Capital Group's PFE Position: Q2 2026 in Review
Cypress Capital Group increased its Pfizer (PFE) stake by 6.3% in Q2 2026, buying an estimated $215K and bringing the position to 138,473 shares worth $3.33M. The position accounts for 0.31% of the portfolio, ranked #76.
Cypress Capital Group first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.37M in Q4 2022. 2,169 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Cypress Capital Group held 138,473 shares of Pfizer worth $3.33M as of Q2 2026.
- Cypress Capital Group bought 8,227 Pfizer shares in Q2 2026, an estimated $215K.
- Pfizer made up 0.31% of Cypress Capital Group's portfolio in Q2 2026, its #76 holding.
- Cypress Capital Group first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Cypress Capital Group's Pfizer position peaked at $7.37M in Q4 2022.
- 2,169 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Cypress Capital Group's 13F filing for Q2 2026, filed 5 Aug 2026.